Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

In vitro pemphigus vulgaris model using organotypic cultures of human epidermal keratinocytes.

Hunziker T, Boillat C, Gerber HA, Wiesmann U, Wintroub BU.

J Invest Dermatol. 1989 Aug;93(2):263-7.

2.

The ultrastructure of acantholysis in pemphigus vulgaris.

Diercks GF, Pas HH, Jonkman MF.

Br J Dermatol. 2009 Feb;160(2):460-1. doi: 10.1111/j.1365-2133.2008.08971.x. Epub 2008 Dec 11. No abstract available.

PMID:
19120342
3.

In vivo binding site of pemphigus vulgaris antibodies and their fate during acantholysis.

Iwatsuki K, Takigawa M, Imaizumi S, Yamada M.

J Am Acad Dermatol. 1989 Apr;20(4):578-82.

PMID:
2469704
4.

Role of plasminogen activator in pemphigus vulgaris.

Wilkinson JE, Smith CA, Suter MM, Falchek W, Lewis RM.

Am J Pathol. 1989 Mar;134(3):561-9.

5.

Apoptosis is not required for acantholysis in pemphigus vulgaris.

Schmidt E, Gutberlet J, Siegmund D, Berg D, Wajant H, Waschke J.

Am J Physiol Cell Physiol. 2009 Jan;296(1):C162-72. doi: 10.1152/ajpcell.00161.2008. Epub 2008 Nov 5.

6.

Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.

Ohata C, Ishii N, Furumura M.

J Cutan Pathol. 2014 Nov;41(11):880-9. doi: 10.1111/cup.12384. Epub 2014 Nov 3.

PMID:
25265985
7.

Proteinase activation: a mechanism for cellular dyshesion in pemphigus.

Singer KH, Sawka NJ, Samowitz HR, Lazarus GS.

J Invest Dermatol. 1980 May;74(5):363-7.

8.

Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.

Frusić-Zlotkin M, Raichenberg D, Wang X, David M, Michel B, Milner Y.

Autoimmunity. 2006 Nov;39(7):563-75.

PMID:
17101500
9.

An organ culture model for the study of pemphigus acantholysis.

Michel B, Ko CS.

Br J Dermatol. 1977 Mar;96(3):295-302.

PMID:
322692
10.

In vitro acantholysis induced by D-penicillamine, captopril, and piroxicam on dead de-epidermized dermis.

De Dobbeleer G, Godfrine S, Gourdain JM, De Graef C, Heenen M.

J Cutan Pathol. 1992 Jun;19(3):181-6.

PMID:
1401343
11.
12.

Methylprednisolone inhibits pemphigus acantholysis in skin cultures.

Swanson DL, Dahl MV.

J Invest Dermatol. 1983 Sep;81(3):258-60.

13.
14.

Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.

Shu E, Yamamoto Y, Aoyama Y, Kitajima Y.

Arch Dermatol Res. 2007 Jun;299(3):165-7. Epub 2007 Apr 13.

PMID:
17431647
15.

Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem).

Futamura S, Martins C, Rivitti EA, Labib RS, Diaz LA, Anhalt GJ.

J Invest Dermatol. 1989 Oct;93(4):480-5.

17.

Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens.

Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA.

J Biol Chem. 2007 May 4;282(18):13804-12. Epub 2007 Mar 7.

18.

Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.

Femiano F.

Minerva Stomatol. 2007 Apr;56(4):215-23. Review. English, Italian.

19.

Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.

Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA.

J Clin Invest. 2000 Dec;106(12):1467-79.

20.

Immunopathological mechanisms of acantholysis in pemphigus vulgaris: an explanation by ultrastructural observations.

Liu Z, Li N, Diaz LA.

J Invest Dermatol. 2004 May;122(5):XIII-XIV. Review. No abstract available.

Supplemental Content

Support Center